from the quickly evolving field of oncology investigation, precise and successful mutation screening is very important for creating targeted therapies. The KRAS companies System performs a pivotal function Within this landscape by providing comprehensive alternatives for KRAS mutation here profiling and Investigation. KRAS mutations, found in aroun